The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Vertigon 8 mg tablets

8 milligram(s) Tablet

Aurobindo Pharma (Malta) LimitedPA1445/023/001

Main Information

Trade NameVertigon 8 mg tablets
Active SubstancesBetahistine dihydrochloride
Strength8 milligram(s)
Dosage FormTablet
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/023/001

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA01 betahistine

Status

Authorised/WithdrawnAuthorised
Licence Issued03/10/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListBetahistine 8mg Tablets
Interchangeable List CodeIC0084-009-002
Interchangeable List DocumentPDF of Interchangeable List
« Back